TB

his webinar session features a case-based discussion on the management of tuberculosis in alignment with the 2025 ATS/CDC/ERS/IDSA Clinical Practice Guidelines. Lahari Tumuluri, MD (Tulane University), will present two TB cases illustrating the application of these guidelines. Jussi Saukkonen, MD (Boston University), and Charles Daley, MD (National Jewish), will review the guideline development process, supporting evidence, and practical implications for treating drug-sensitive and drug-resistant TB, drawing on real-world clinical experience.

The webinar is to enhance community medical providers’ awareness of latent tuberculosis infection (LTBI). A brief overview of latent tuberculosis vs. active tuberculosis is given along with the most recent numbers of TB cases in NYS and CDC estimates of those with LTBI. It encourages community providers to assess their patients for TB risk factors, then test and treat them for LTBI as indicated.

This webinar recording discusses tests for TB and drug resistance. It also reviews TB screening, diagnosis, treatment monitoring, and more. 

This report evaluates the current needs, protocols, and promising practices for latent tuberculosis infection (LTBI) and tuberculosis (TB) screening, testing, and treatment among community health centers serving Asian American/Asian (A/AA) and Native Hawaiian/Pacific Islander (NH/PI) populations.

This report summarizes the TB Elimination Alliance's (TEA) activities and outcomes from 2019 to 2024.

This webpage explains Assembly Bill 2132, which mandates tuberculosis (TB) risk assessment and testing for adult primary care patients in California.

This information sheet outlines the steps in the tuberculosis (TB) care cascade, from diagnosis to treatment completion. It highlights the importance of accurate testing, adherence to treatment, and use of directly observed therapy to ensure successful outcomes and prevent TB transmission.

This guideline provides updated, evidence-based recommendations for diagnosing, treating, and managing latent tuberculosis infection (LTBI). It offers practical guidance for healthcare providers and public health programs, including testing options, treatment regimens, and considerations for special populations.

This webpage outlines treatment approaches for both inactive and active tuberculosis (TB), including medication regimens, side effects, adherence tips, and steps to prevent the spread of TB. It emphasizes the importance of taking TB medications as prescribed to ensure successful recovery and protect others.

This video provides a clear, detailed demonstration of the steps involved in administering and reading the Mantoux tuberculin skin test.